2021
Immunotherapy-Related Acute Kidney Injury
Manohar S, Jhaveri KD, Perazella MA. Immunotherapy-Related Acute Kidney Injury. Advances In Kidney Disease And Health 2021, 28: 429-437.e1. PMID: 35190109, DOI: 10.1053/j.ackd.2021.07.006.Peer-Reviewed Original ResearchConceptsChimeric antigen receptor T-cell therapyEffective immune checkpoint inhibitorsAcute kidney injuryImmune checkpoint inhibitorsHigh-dose interleukinNumerous clinical trialsT-cell therapyField of oncologyCheckpoint inhibitorsKidney injuryGeneration immunotherapiesClinical trialsClinical practiceImmunotherapyImmune systemAdverse effectsNephrotoxicityInterleukinPathophysiologyInjuryTherapyCancerOncologyTrials
2020
The kidney–cancer connection continues to grow
Perazella M. The kidney–cancer connection continues to grow. Journal Of Onco-Nephrology 2020, 4: 26-27. DOI: 10.1177/2399369320916474.Peer-Reviewed Original Research
2019
Evolution of the kidney–cancer connection
Perazella M, Workeneh B, Chen S. Evolution of the kidney–cancer connection. Journal Of Onco-Nephrology 2019, 3: 88-91. DOI: 10.1177/2399369319841616.Peer-Reviewed Original ResearchOnco-NephrologyKidney diseaseCare medicineMD Anderson Cancer CenterPalliative care medicineAnderson Cancer CenterCritical care medicineCancer CenterClinical pharmacologyClinical practiceAreas of medicineCancerDiseaseSpecialty groupsPatientsClinical medicineHighlights sectionMedicineTherapyNephrologyOncologyHematologyUrologyPharmacology
2009
CHAPTER 184 The Role of Extracorporeal Blood Purification Therapies in the Prevention of Radiocontrast Agent—Induced Nephropathy
Cruz D, Perazella M, Ronco C. CHAPTER 184 The Role of Extracorporeal Blood Purification Therapies in the Prevention of Radiocontrast Agent—Induced Nephropathy. 2009, 1000-1006. DOI: 10.1016/b978-1-4160-4252-5.50193-3.Peer-Reviewed Original Research
2001
Pharmacologic options available to treat symptomatic intradialytic hypotension
Perazella M. Pharmacologic options available to treat symptomatic intradialytic hypotension. American Journal Of Kidney Diseases 2001, 38: s26-s36. PMID: 11602458, DOI: 10.1053/ajkd.2001.28092.Peer-Reviewed Original ResearchConceptsSymptomatic intradialytic hypotensionIntradialytic hypotensionHigh-risk patientsLower blood pressurePharmacologic optionsPharmacologic therapyBlood pressurePatient factorsAvailable therapiesPharmacologic interventionsHypotensionTherapyTreatmentInitial approachMidodrineNephrologistsPatientsSertraline
1998
Acute Renal Failure and Intravenous Immune Globulin
Perazella M, Cayco A. Acute Renal Failure and Intravenous Immune Globulin. American Journal Of Therapeutics 1998, 5: 399-404. PMID: 10099084, DOI: 10.1097/00045391-199811000-00008.Peer-Reviewed Original ResearchConceptsAcute renal failureRenal failureRenal insufficiencyIntravenous immune globulin therapyImmune globulin therapyChronic renal insufficiencyIntravenous immune globulinAcute renal insufficiencyRenal replacement therapyVariety of complicationsGlobulin therapyIVIG infusionIVIG therapyMaintenance dialysisRenal impairmentImmune globulinIVIG preparationsReplacement therapyDrug trialsNumber of casesClinical disordersOlder agePrecise causeTherapyAdverse effects
1997
Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature.
Cayco A, Perazella M, Hayslett J. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. Journal Of The American Society Of Nephrology 1997, 8: 1788-94. PMID: 9355083, DOI: 10.1681/asn.v8111788.Peer-Reviewed Original ResearchConceptsIntravenous immune globulin therapyAcute renal failureImmune globulin therapyGlobulin therapyRenal replacement therapyNumber of complicationsIVIG treatmentRenal insufficiencyRenal failureRenal injuryIVIG preparationsSuch patientsReplacement therapyClinical disordersTherapyCases recoveryComplicationsPatientsRecurrenceWidespread useInjuryInsufficiencyAgentsCasesBiochemical aberrations in a dialysis patient following parathyroidectomy
Cruz D, Perazella M. Biochemical aberrations in a dialysis patient following parathyroidectomy. American Journal Of Kidney Diseases 1997, 29: 759-768. PMID: 9159312, DOI: 10.1016/s0272-6386(97)90131-1.Peer-Reviewed Original ResearchConceptsEnd-stage renal diseaseSevere secondary hyperparathyroidismCalcitriol therapySurgical parathyroidectomyIntensive regimenSecondary hyperparathyroidismElectrolyte abnormalitiesRenal osteodystrophySevere hypocalcemiaDialysis patientsRenal diseasePostoperative managementHigh riskParathyroidectomyPatientsBiochemical aberrationsCommon problemHyperparathyroidismHypocalcemiaHyperkalemiaHypophosphatemiaOsteodystrophyRegimenAberrationsTherapy